Ayelet Rachel Peretz

Ms. Ayelet Rachel Peretz


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SAShelly Mahlab Aviv
Shelly Mahlab Aviv
KZKeren Zohar
Keren Zohar
YCYael Cohen
Yael Cohen
APAyelet Rachel Peretz
Ayelet Rachel Peretz
TETsiona Eliyahu
Tsiona Eliyahu
RSRuth Sperling
Ruth Sperling
MicroRNAs (miRNAs) act as negative regulators of gene expression in the cytoplasm. Previous studies have identified the presence of miRNAs in the nucleus. Here we study human breast cancer-derived cell-lines (MCF-7 and MDA-MB-231) and a non-tumorigenic cell-line (MCF-10A) and compare their miRNA sequences at the spliceosome fraction (SF). We report that the levels of miRNAs found in the spliceosome, their identity, and pre-miRNA segmental composition are cell-line specific. One such miRNA is miR-7704 whose genomic position overlaps HAGLR, a cancer-related lncRNA. We detected an inverse expression of miR-7704 and HAGLR in the tested cell lines. Specifically, inhibition of miR-7704 caused an increase in HAGLR expression. Furthermore, elevated levels of miR-7704 slightly altered the cell-cycle in MDA-MB-231. Altogether, we show that SF-miR-7704 acts as a tumor-suppressor gene with HAGLR being its nuclear target. The relative levels of miRNAs found in the spliceosome fractions (e.g., miR-100, miR-30a, and let-7 family) in non-tumorigenic relative to cancer-derived cell-lines was monitored. We found that the expression trend of the abundant miRNAs in SF was different from that reported in the literature and from the observation of large cohorts of breast cancer patients, suggesting that many SF-miRNAs act on targets that are different from the cytoplasmic ones. Altogether, we report on the potential of SF-miRNAs as an unexplored route for cancerous cell state.

20 October 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NBNetta Barak
Netta Barak
RBRoni Ben-Ami
Roni Ben-Ami
TSTal Sido
Tal Sido
APAmir Perri
Amir Perri
ASAviad Shtoyer
Aviad Shtoyer
MYMoran Yassour
Moran Yassour
Pooling multiple swab samples prior to RNA extraction and RT-PCR analysis was proposed as a strategy to reduce costs and increase throughput of SARS-CoV-2 tests. However, reports on practical large-scale group testing for SARS-CoV-2 have been scant. Key open questions concern reduced sensitivity due to sample dilution; the rate of false positives; the actual efficiency (number of tests saved by pooling) and the impact of infection rate in the population on assay performance. Here we report analysis of 133,816 samples collected at April-September 2020, tested by pooling for the presence of SARS-CoV-2. We spared 76% of RNA extraction and RT-PCR tests, despite the reality of frequently changing prevalence rate (0.5%-6%). Surprisingly, we observed pooling efficiency and sensitivity that exceed theoretical predictions, which resulted from non-random distribution of positive samples in pools. Overall, the findings strongly support the use of pooling for efficient large high throughput SARS-CoV-2 testing.

Verified
Journal Article
Open access
PDF file
SAShelly Mahlab Aviv
Shelly Mahlab Aviv
KSKeren Or Swissa
Keren Or Swissa
MAMaram Arafat
Maram Arafat
KZKeren Zohar
Keren Zohar
APAyelet Rachel Peretz
Ayelet Rachel Peretz
RSRuth Sperling
Ruth Sperling
MicroRNAs (miRNAs) are well known for regulating translation in the cytoplasm, yet their nuclear roles remain poorly understood. Previously, we identified spliceosome-associated miRNAs implicated in tumorigenesis and metastasis in breast cancer models. Here, we investigate their nuclear functions in the immortalized human cortical neuron (HCN) cell line, along with glioblastoma (U87MG) and neuroblastoma (SH-SY5Y) cell lines, both widely used as models for brain cancer research. Our findings reveal that spliceosome-associated miRNAs mark neuronal cancer cells and uncover novel nuclear targets. Notably, some spliceosomal miRNAs exhibit opposing regulatory effects in the nucleus compared to the cytoplasm, while others demonstrate potential novel nuclear functions. A prominent example is miR-99b, which overlaps the 5′ splice junction of the poorly characterized long non-coding RNA (lncRNA) sperm acrosome-associated 6 antisense RNA1 (SPACA6-AS1) and, through base pairing, enhances SPACA6-AS1 pre-mRNA levels. These results highlight the diverse and context-dependent functions of nuclear miRNAs in gene regulation and cancer progression, broadening our understanding of their regulatory potential beyond the cytoplasm.

20 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SMShelly Mahlab-Aviv
Shelly Mahlab-Aviv
KZKeren Zohar
Keren Zohar
YCYael Cohen
Yael Cohen
APAyelet Rachel Peretz
Ayelet Rachel Peretz
TETsiona Eliyahu
Tsiona Eliyahu
RSRuth Sperling
Ruth Sperling
MicroRNAs (miRNAs) act as negative regulators of gene expression in the cytoplasm. Previous studies identified miRNAs associated with the spliceosome. Here we study three breast-derived cell-lines with increased tumorigenicity (from MCF-10A to MCF-7 and MDA-MB-231) and compared their miRNA sequences at the spliceosome fraction (SF). We report that the SF-miRNAs expression, identity, and pre-miRNA segmental composition vary across these cell-lines. The expression of the majority of the abundant SF-miRNAs (e.g. miR-100, miR-30a, and let-7 members) shows an opposite trend in view of the literature and breast cancer large cohorts. The results suggest that SF-miRNAs act in the nucleus on alternative targets than in the cytoplasm. One such miRNA is miR-7704 whose genomic position overlaps HAGLR, a cancer-related lncRNA. We found an inverse expression of miR-7704 and HAGLR in the tested cell lines. Moreover, inhibition of miR-7704 caused an increase in HAGLR expression. Furthermore, increasing miR-7704 levels attenuated the MDA-MB-231 cell-division rate. While miR-7704 acts as oncomiR in breast cancer patients, it has a tumor-suppressing function in SF, with HAGLR being its nuclear target. Manipulating miR-7704 levels is a potential lead for altering tumorigenicity. Altogether, we report on the potential of manipulating SF-miRNAs as an unexplored route for breast cancer therapeutics.

8 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SAShelly Mahlab Aviv
Shelly Mahlab Aviv
KSKeren Or Swissa
Keren Or Swissa
MAMaram Arafat
Maram Arafat
KZKeren Zohar
Keren Zohar
APAyelet Rachel Peretz
Ayelet Rachel Peretz
RSRuth Sperling
Ruth Sperling
MicroRNAs (miRNAs) are well-known for regulating translation in the cytoplasm, yet their roles in the nucleus remain poorly understood. Previously, we identified spliceosome-associated miRNAs implicated in tumorigenesis and metastasis in breast cancer models. Here, we investigate their nuclear functions in immortalized human cortical neurons (HCN) cell line, along with brain cancer derived cell lines of glioblastoma (U87MG) and neuroblastoma (SH-SY5Y) that are widely used as models for brain cancer research. Our findings reveal that spliceosome-associated miRNAs mark neuronal cancer cells and uncover novel nuclear targets. Interestingly, some spliceosomal miRNAs exhibit opposing regulatory effects in the nucleus compared to the cytoplasm, while some portray potential novel nuclear functions. A notable example is miR-99b, which overlaps the 5’ splice junction of the poorly characterized long non-coding RNA (lncRNA) SPACA6-AS1 and, through base-pairing, enhances SPACA6-AS1 pre-mRNA levels. These findings highlight the diverse and context-dependent functions of nuclear miRNAs in gene regulation and cancer progression, expanding our understanding of their regulatory potential beyond the cytoplasm.